Home » Newsletters » BioWorld Science

BioWorld Science

March 16, 2020

View Archived Issues

OyaGen to develop OYA-1 for the treatment of coronaviruses

Denali studies DNL-343 in healthy volunteers in new phase I trial

Researchers present phase II data for tafoxiparin in women in labor

Aclaris initiates phase IIa study of ATI-450 with methotrexate for moderate to severe RA

Chlorotoxin-CAR T cells specifically targeting glioblastomas shows preclinical antitumor activity

Poseida Therapeutics initiates phase I study of P-PSMA-101 CAR-T cells

Patient enrollment ongoing in phase I study of CS-3002

Phase IIb ARISE study of padsevonil does not reach statistical significance for primary endpoints

Anti-POTEF autoantibodies as new biomarker in primary ovarian insufficiency

NPSR1 as a novel nonhormonal target in endometriosis

First-in-human data for (R,R)-penehyclidine fumarate

New approach to cancer immunotherapy identified

FDA clears IND for phase I/II trial of Adaptive Phage Therapeutics' PhageBank

Researchers develop murine model of CMV infection in pregnancy

See in 3D

PharmaMar reports promising in vitro study results with Aplidin against coronavirus HCoV-229E

University of Edinburgh discloses new cyclophilin inhibitors

New glutaminyl cyclase inhibitors patented by Academia Sinica, NHRI

Daewoong Pharmaceutical describes dual BTK/ITK inhibitors

Merck KGaA discovers Bruton tyrosine kinase inhibitors

New pantetheinase inhibitors presented by Boehringer Ingelheim

Janssen collaborates with Beth Israel Deaconess on preventive vaccine candidate for COVID-19

Algernon to seek funding from COVID-19 Therapeutic Accelerator program for repurposed drug

Preclinical data show PAT-DX1 crosses blood-brain barrier via ENT2 pathway

Japanese approval for new Ozempic SD subcutaneous injection formulation

Kevzara enters global clinical program for use in severe COVID-19 infection

Trial of darunavir/cobicistat and hydroxychloroquine to reduce transmission of SARS-CoV-2 begins

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...